Skip to content
StockMarketAgent
Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

MUN/1HM stock hub

MUN/1HM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MUN/1HMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.9B
Munich Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
MUN/1HM
In the news

Latest news · MUN/1HM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-24
P25 n/aP50 n/aP75 n/a
ROIC-6.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MUN/1HM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
165
Groups with data
11
Currency
USD
Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
624
Employees Change
-90%
Employees Change Percent
-12.69
Enterprise value
EUR 1.9B
Exchange
Munich Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
In Vitro and In Vivo Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.9B
Price
EUR 13.88
Price currency
EUR
Rev Per Employee
410,587.33x
Sic
2835
Symbol
mun/1HM
Website
https://www.adaptivebiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-2.29%
EV Earnings
-43.16x
EV/FCF
-72.61x
EV/Sales
7.41x
FCF yield
-1.36%
P/B ratio
9.66x
P/S ratio
7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
-15.82%
EBITDA Margin
-10.08%
Gross margin
43.71%
Gross Profit
EUR 112M
Gross Profit Growth
497.6%
Gross Profit Growth Q
153.47%
Net Income
EUR -43.1M
Pretax Margin
-16.8%
Profit Margin
-16.82%
Profit Per Employee
EUR -69,050
ROA
-5.74
Roa5y
-13.29
ROCE
-11.15
ROE
-23.95
Roe5y
-43.39
ROIC
-6.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
137.57%
Cagr3y
11.54%
Cagr5y
-21.85%
Revenue Growth
55.87x
Revenue Growth Q
35.15x
Revenue Growth3 Y
17.02x
Revenue Growth5 Y
20.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.58
Assets
EUR 438.8M
Cash
EUR 189.4M
Current Assets
EUR 247.4M
Current Liabilities
EUR 73.8M
Debt
EUR 180.6M
Debt Equity
EUR 0.93
Debt FCF
EUR -7.05
Equity
EUR 194.5M
Interest Coverage
-3.97
Liabilities
EUR 244.3M
Long Term Assets
EUR 191.4M
Long Term Liabilities
EUR 170.5M
Net Cash
EUR 25.2M
Net Cash By Market Cap
EUR 1.34
Net Cash Growth
135.77%
Net Debt Equity
EUR -0.13
Tangible Book Value
EUR 83.3M
Tangible Book Value Per Share
EUR 0.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.35
Inventory Turnover
16.72
Net Working Capital
EUR 675,627
Quick ratio
3.08
Working Capital
EUR 177.6M
Working Capital Turnover
EUR 1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
137.43%
200-day SMA
34.73
3Y total return
38.77%
50-day SMA
14.47
50-day SMA vs 200-day SMA
50under200
5Y total return
-70.84%
All Time High
58.5
All Time High Change
-76.27%
All Time High Date
2021-01-18
All Time Low
3.44
All Time Low Change
304.08%
All Time Low Date
2024-08-05
ATR
1.16
Ch YTD
-5.9
High
13.89
High52
15.32
High52 Date
2025-10-21
High52ch
-9.37%
Low
13.88
Low52
6.89
Low52 Date
2025-01-16
Low52ch
101.33%
Ma50ch
-4.05%
Price vs 200-day SMA
-60.03%
RSI
58.74
RSI Monthly
44.3
RSI Weekly
38.86
Sharpe ratio
-0.01x
Sortino ratio
0.02
Total Return
-3.62%
Tr YTD
-5.9
Tr1m
7.51%
Tr1w
2.89%
Tr3m
47.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -40.5M
Operating margin
-15.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
125,373,598%
Shares Insiders
2.92%
Shares Institutions
79.68%
Shares Qo Q
1.56%
Shares Yo Y
3.62%
Short Ratio
4.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR -70.1M
Average Volume
184.3x
Bv Per Share
1.17
CAPEX
EUR -2.2M
Ch1m
7.51
Ch1w
2.89
Ch1y
137.4
Ch3m
47.03
Ch3y
38.77
Ch5y
-70.84
Ch6m
47.03
Change
-1.28%
Change From Open
-0.07
Close
14.06
Days Gap
-1.21
Depreciation Amortization
14,363,628.3
Dollar Volume
277.6
Earnings Date
2026-05-05
EBIT
EUR -40.5M
EBITDA
EUR -25.8M
EPS
EUR -0.28
F Score
5
FCF
EUR -25.6M
FCF EV Yield
-1.38x
Financing CF
28,145,620
Fiscal Year End
December
Founded
2,009
Goodwill
100,883,735.1
Investing CF
18,664,296
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Ma150
32.6
Ma150ch
-57.43%
Ma20
9.07
Ma20ch
52.98%
Net CF
23,358,991
Open
13.89
Position In Range
0
Ppne
60,223,957.2
Price Date
2026-01-09
Ptbv Ratio
22.54
Relative Volume
0.11x
Revenue
256,206,491x
SBC By Revenue
17.35x
Share Based Comp
44,461,267
Tr6m
47.03%
Volume
20
Z Score
1.28
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MUN/1HM pay a dividend?

Capital-return profile for this ticker.

Performance

MUN/1HM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+137.4%
S&P 500 1Y: n/a
3Y total return
+38.8%
S&P 500 3Y: n/a
5Y total return
-70.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns MUN/1HM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+79.7%
Share of float held by funds and institutions
Insider ownership
+2.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.4 days to cover
Y/Y dilution
+3.6%
Negative means the company is buying back shares.
Technical

MUN/1HM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.7
Neutral momentum band
Price vs 200-day MA
-60.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About MUN/1HM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current mun/1HM stock rating?

mun/1HM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full mun/1HM analysis?

The full report lives at /stocks/mun/1HM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for mun/1HM?

The latest report frames mun/1HM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the mun/1HM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

mun/1HM stock profile: metrics, valuation and analysis | StockMarketAgent.AI